Has David Seigler, MD received payments from drug or device companies?

Yes. Drug and device makers reported $37,146 in general payments to David Seigler, MD across 58 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Seigler, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Seigler, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Seigler, MD

Psychiatry · Riverside, CANPI 1023396132

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $24,150 of the $37,146 with a category attached, or 65.0%. Boehringer Ingelheim accounts for 76.2% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $20,360 and has fallen 87.1% since, to $2,625 in 2025. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$37,146in general payments, 2019–2025

Across 58 payments — averaging $640.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boehringer Ingelheim$28K
Bioxcel Therapeutics, Inc.$8K
Johnson & Johnson$294
Neurocrine Biosciences, Inc.$125
Alkermes, Inc.$11

What the payments were for

Consulting fees$24,15065%
Speaking & faculty fees$6,26017%
Travel & lodging$5,46115%
Food & beverage$1,1093%
Education$1660%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boehringer Ingelheim	29	$28,294
Bioxcel Therapeutics, Inc.	23	$8,421
Johnson & Johnson	4	$294
Neurocrine Biosciences, Inc.	1	$125
Alkermes, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,146 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Medicare billing

Part B allowed, 2024

$11,005

Medicare patients

Services billed

118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatry in Riverside

Ramesh PatelRiverside$112K
Deepak RajpootRiverside$109K
Gustavo AlvaOrange$5.8M
John KooSan Francisco$3M
Jason KelloggIrvine$2.7M
Jonathan MeyerSan Diego$2.3M
Charles Tuan-Tu NguyenIrvine$2.1M
Manoj WaikarLos Gatos$1.9M
Gerald MaguireSan Juan Capistraco$1.8M
Salima BrillmanSunnyvale$1.4M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →